NCT01340794 2017-09-21Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or ParagangliomaNational Cancer Institute (NCI)Phase 2 Terminated7 enrolled 8 charts